RxDoctor Payments Data

James Dunnan, MD

Family Medicine · Dublin, OHNPI 1801840194

Payments from drug & device makers

$1,710in general payments, 2019–2025

Across 113 payments — averaging $15.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$898
  • GSK$117
  • Johnson & Johnson$115
  • Lilly USA, LLC$91
  • Novo Nordisk$87
  • AstraZeneca$74
  • plus $328 from 13 others

What the payments were for

  • Food & beverage$1,710100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,710 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$65,126
Medicare patients
218
Services billed
1,794

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban168$157,410
OzempicSemaglutide61$97,553
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$38,616
FarxigaDapagliflozin Propanediol24$36,837
XifaxanRifaximin11$32,840
MyrbetriqMirabegron64$27,073
XareltoRivaroxaban26$24,117
TrulicityDulaglutide22$22,288
JardianceEmpagliflozin33$19,569
JanuviaSitagliptin Phosphate27$18,460
TradjentaLinagliptin21$12,469
Aripiprazole28$11,723
RybelsusSemaglutide11$10,416
Duloxetine Hcl177$9,257
Atorvastatin Calcium747$9,172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$32$157,410168 claims
Novo NordiskOzempic, Rybelsus$87$107,96872 claims
GSKTrelegy Ellipta, Shingrix$117$44,56867 claims
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat$36$39,31865 claims
AstraZenecaFarxiga$74$36,83724 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$17$32,84011 claims
Johnson & JohnsonXarelto$115$24,11726 claims
Lilly USA, LLCTrulicity$91$22,28822 claims
MerckJanuvia$46$18,46027 claims
AbbVieLinzess, Synthroid$898$10,50257 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Dublin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →